https://www.selleckchem.com/pr....oducts/ag-120-Ivosid
ALA 3x reduced NMSC development versus VEH (5 vs 12 lesions, P=0.0014). Conclusion 2 or 3 ALA–PDT treatments with 1-hour incubation can significantly reduce occurrence of AKs after 1 year in patients at high risk of NMSC versus VEH–PDT (NCT02239679). J Drugs Dermatol. 2020;19(5)452-458. doi10.36849/JDD.2020.4930.Background Previous results from two phase 3 studies demonstrated efficacy and safety of fixed combination halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in participants with moderate-to-severe plaque p